↓ Skip to main content

Dove Medical Press

Article Metrics

Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity

Overview of attention for article published in Drug Design, Development and Therapy, January 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
14 Mendeley
Title
Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity
Published in
Drug Design, Development and Therapy, January 2015
DOI 10.2147/dddt.s72844
Pubmed ID
Authors

Philip Lazarovici, Tatjana Momic, Jehoshua Katzehendler, Ela Shai, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz, David Varon

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 7%
Unknown 13 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 21%
Student > Master 3 21%
Student > Ph. D. Student 3 21%
Professor 1 7%
Student > Bachelor 1 7%
Other 2 14%
Unknown 1 7%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Medicine and Dentistry 2 14%
Agricultural and Biological Sciences 2 14%
Biochemistry, Genetics and Molecular Biology 2 14%
Computer Science 1 7%
Other 1 7%
Unknown 3 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2015.
All research outputs
#10,012,017
of 12,510,237 outputs
Outputs from Drug Design, Development and Therapy
#765
of 1,315 outputs
Outputs of similar age
#157,066
of 225,886 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 34 outputs
Altmetric has tracked 12,510,237 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,315 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,886 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.